Resistance mechanism against fluoroquinolones in Mycoplasma hyopneumoniae field isolates

Microbial Drug Resistance

Volumn 13, Issue 3, 2007, Pages 166-170

  Vicca, J ^a,d   Maes, D ^a   Stakenborg, T ^b   Butaye, P ^b   Minion, F ^c   Peeters, J ^b   De Kruif, A ^a   Decostere, A ^a   Haesebrouck, F ^a  

^a GHENT UNIVERSITY   (Belgium)

^b VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

^c IOWA STATE UNIVERSITY   (United States)

^d KaHo St Lieven Polytechnics ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; ENROFLOXACIN; FLUMEQUINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE; TYROSINE; VALINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM MUTANT; BIOMECHANICS; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA HYOPNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL;

AMINO ACID SUBSTITUTION; ANIMALS; ANTI-INFECTIVE AGENTS; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; GENES, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA HYOPNEUMONIAE; POINT MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SWINE;

ESCHERICHIA COLI; MYCOPLASMA HYOPNEUMONIAE;

EID: 34548618478     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2007.716     Document Type: Article

References (42)

1. Aarestrup, F.M., S.E. Jorsal, and N.E. Jensen. 1998. Serological characterization and antimicrobial susceptibility of Streptococcus suis isolates from diagnostic samples in Denmark during 1995 and 1996. Vet. Microbiol. 60:59-66.
2. Baucheron, S., E. Chaslus-Dancla, and A. Cloekaert. 2004. Role of TolC and parC mutation in high-level fluoroquinolone resistance in Salmonella enterica serotype Typhimurium DT 204. J. Antimicrob. Chemother. 53:657-659.
3. Bébéar, C.M., O. Grau, A. Charron, H. Renaudin, D. Gruson, and C. Bébéar. 2000. Cloning and nucleotide sequence of the DNA gyrase (gyrA) gene from Mycoplasma hominis and characterization of quinolone-resistant mutants selected in vitro with trovofloxacin. Antimicrob. Agents Chemother. 44:2719-2727.
4. Bébéar, C.M., H. Renaudin, A. Charron, J.M. Bove, C. Bébéar, and J. Renaudin. 1998. Alterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of Mycoplasma hominis obtained in vitro. Antimicrob. Agents Chemother. 42:2304-2311.
5. Bébéar, C.M., H. Renaudin, A. Charron, M. Clerc, S. Pereyre, and C. Bébéar. 2003. DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones. Antimicrob. Agents Chemother. 47:3323-3325.
6. Bébéar, C.M., J. Renaudin, A. Charron, H. Renaudin, B. de Barbeyrac, T. Schaeverbeke, and C. Bébéar. 1999. Mutations in the gyrA, parC and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis. Antimicrob. Agents Chemother. 43:954-956.
7. Belland, R.J., S.G. Morrison, C. Ison, and W.M. Huang. 1994. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol. Microbiol. 14:371-380.
8. Davies, T.A., and R. Goldschmidt. 2002. Screening of large numbers of Streptococcus pneumoniae isolates for mutations associated with fluoroquinolone resistance using an oligonucleotide probe assay. FEMS Microbiol. Lett. 217:219-224.
9. Deguchi, T., A. Fukuoka, M. Yasuda, M. Nakano, S. Ozeki, E. Kanematsu, Y. Nishino, S. Ishihara, Y. Ban, and Y. Kawada. 1997. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 41:699-701.
10. Ferrero, L., B. Cameron, and J. Crouzet. 1995. Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin- resistant mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 39:1554-1558.
11. Fukuda, H., and K. Hiramatsu. 1999. Primary targets of fluoroquinolones in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43:410-412.
12. Gellert, M. 1981. DNA topoisomerases. Annu. Rev. Biochem. 50:879-910.
13. Georgiou, M., R. Muñoz, F. Román, R. Canton, R. Gomez-Lus, J. Campos, and A.G. De La Campa. 1996. Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC. Antimicrob. Agents Chemother. 40:1741-1744.
14. Hannan, P. C., G. D. Windsor, A. de Jong, N. Schmeer, and M. Stegemann. 1997. Comparitive susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones. Antimicrob. Agents Chemother. 41:2037-2040.
15. Hawkey, P.M. 2003. Mechanism of quinolone action and microbial response. J. Antimicrob. Chemother. 51(Suppl.1):29-35.
16. Hirose, K., Y. Kawasaki, and K. Kotani. 2004. Characterization of a point mutation in the parC gene of Mycoplasma bovirhinis associated with fluoroquinolone resistance. J. Vet. Med. B 51:169-175.
17. Hooper, D.C. 1999. Mechanisms of fluoroquinolone resistance. Drug Resist. Updat. 2:38-55.
18. Hooper, D.C. 2000. Mechanism of action and resistance of older and newer fluoroquinolones. Clin. Infect. Dis. 31(Suppl.2):24-28.
19. Kaatz, G.W., V.V. Moudgal, and S. Seo. 2002. Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus. J. Antimicrob. Chemother. 50:833-838.
20. Kanematsu, E., T. Deguchi, M. Yasuda, T. Kawamura, Y. Nishino, and Y. Kawada. 1998. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV associated with quinolone resistance in Enterococcus faecalis. Antimicrob. Agents Chemother. 42:433-435.
21. Khodursky, A.B., E.L. Zechiedrich, and N.R. Cozzarelli. 1995. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc. Natl. Acad. Sci. USA 92:11801-11802.
22. Le Carrou, J., M. Laurentie, M. Kobisch, and A.V. Gautier-Bouchardon. 2006. Persistence of Myoplasma hyopneumoniae in experimentally infected pigs after marbofloxacin treatment and detection of mutations in the parC gene. Antimicrob. Agents Chemother. 50:1959-1966.
23. Martel, A., M. Baele, L. A. Devriese, H. Goossens, H.J. Wisselink, A. Decostere, and F. Haesebrouck. 2001. Prevalence and mechanism of resistance against macrolides and lincosamides in Streptococcus suis isolates. Vet. Microbiol. 83:287-297.
24. Martinéz-Martinéz, L., A. Pascual, and G.A. Jacoby. 1998. Quinolone resistance from a transferable plasmid. Lancet 335:797-799.
25. Minion, F.C., E.J. Lefkowitz, M.L. Madsen, B.J. Cleary, S. M. Swartzell, and G.G. Mahairas. 2004. The genome sequence of Mycoplasma hyopneumoniae strain 232, the agent of swine mycoplasmosis. J. Bacteriol. 186:7123-7133.
26. National Committee for Clinical Laboratory Standards (NCCLS). 2002. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard, 2nd edn. NCCLS document M31-A2, Wayne, PA.
27. Ng, E.Y., M. Trucksis, and D.C. Hooper. 1996. Quinolone resistance mutations in topoisomerase IV: relationship of the flqA locus and genetic evidence that topoisomerase IV is the primary target of fluoroquinolones in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:1881-1888.
28. Nikaido, H., and D.G. Thanassi. 1993. Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples. Antimicrob. Agents Chemother. 37:1393-1399.
29. Oh, H., J. Stenhoff, S. Jalal, and B. Wretlind. 2003. Role of efflux pumps and mutations in genes for topoisomerase II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strains. Microb. Drug Resist. 9:323-328.
30. Oh, W.S., J.Y. Suh, J.H. Song, K.S. Ko, S.I. Jung, K.R. Peck, N.Y. Lee, Y. Yang, A. Chongthaleong, C.H. Chiu, A. Kamarulzaman, N. Parasakthi, M.K. Lalitha, J. Perera, T.T. Yee, G. Kumarasinghe, and C.C. Carlos. 2004. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study. Microb. Drug Resist. 10:37-42.
31. Raherison, S., P. Gonzales, H. Renaudin, A. Charron, C. Bébéar, and C.M. Bébéar. 2002. Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis. Antimicrob. Agents Chemother. 46:672-679.
32. Reinhardt, A.K., C.M. Bébéar, M. Kobisch, I. Kempf, and A.V. Gautier-Bouchardon. 2002. Characterization of mutations in DNA gyrase and topoisomerase IV involved in quinolone resistance of Mycoplasma gallisepticum mutants obtained in vitro. Antimicrob. Agents Chemother. 46:590-593.
33. Reinhardt, A.K., I. Kempf, M. Kobisch, and A.V. Gautier-Bouchardon. 2002. Fluoroquinolone resistance in Mycoplasma gallisepticum: DNA gyrase as primary target of enrofloxacin and impact of mutations in topoisomerases on resistance level. J. Antimicrob. Chemother. 50:589-592.
34. Schmitz, F.J., M.E. Jones, B. Hofmann, B. Hansen, S. Scheuring, M. Luckefahr, A. Fluit, J. Verhoef, U. Hadding, H.P. Heinz, and K. Kohrer. 1998. Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC. Antimicrob. Agents Chemother. 42:1249-1252.
35. Timmerman, T., J. Dewulf, B. Catry, B. Feyen, G. Opsomer, A. de Kruif, and D. Maes. 2004. Quantification and evaluation of antimicrobial drug use in group treatments for fattening pigs in Belgium. Prev. Vet. Med. 74:251-263.
36. Vicca, J., T. Stakenborg, D. Maes, P. Butaye, J. Peeters, A. de Kruif, and F. Haesebrouck. 2004. In vitro susceptibility of Mycoplasma hyopneumoniae field isolates. Antimicrob. Agents Chemother. 48:4470-4472.
37. Wallmann, J., K. Schröter, L.H. Wieler, and R. Kröker. 2003. National antibiotic resistance monitoring in veterinary pathogens from sick food-producing animals: the German programme and results from the 2001 pilot study. Int. J. Antimicrob. Agents. 22:420-428.
38. World Health Organization. 1998. Use of quinolones in food animals and potential impact on human health. Accessed at http://www.who.int/emc- documents/zoonoses/docs/whoemczdi9810.html#Quinolone%20use%20in%20animals on February 15, 2005.
39. Yamagishi, J-I., T. Kojima, Y. Oyamada, K. Fujimoto, H. Hattori, S. Nakamura, and M. Inoue. 1996. Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:1157-1163.
40. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determing region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.
41. Yoshida, H., M. Nakamura, M. Bogaki, H. Ito, T. Kojima, H. Hattori, and S. Nakamura. 1993. Mechanism of action of quinolones against Escherichia coli DNA gyrase. Antimicrob. Agents Chemother. 37:839-845.
42. Yoshimura, H., A. Kojima, and M. Ishimaru. 2000. Antimicrobial susceptibility of Arcanobacterium pyogenes isolated from cattle and pigs. J. Vet. Med. B 47:139-143.